Cite
Greater time spent with HbA1c less than 7.0% with oral semaglutide versus oral comparators: An exploratory analysis of the PIONEER studies.
MLA
Rosenstock, Julio, et al. “Greater Time Spent with HbA1c Less than 7.0% with Oral Semaglutide versus Oral Comparators: An Exploratory Analysis of the PIONEER Studies.” Diabetes, Obesity & Metabolism, vol. 26, no. 2, Feb. 2024, pp. 532–39. EBSCOhost, https://doi.org/10.1111/dom.15339.
APA
Rosenstock, J., Cariou, B., Eliasson, J., Frappin, G., Kaltoft, M. S., Montanya, E., & Knop, F. K. (2024). Greater time spent with HbA1c less than 7.0% with oral semaglutide versus oral comparators: An exploratory analysis of the PIONEER studies. Diabetes, Obesity & Metabolism, 26(2), 532–539. https://doi.org/10.1111/dom.15339
Chicago
Rosenstock, Julio, Bertrand Cariou, Johanna Eliasson, Guillaume Frappin, Margit S. Kaltoft, Eduard Montanya, and Filip K. Knop. 2024. “Greater Time Spent with HbA1c Less than 7.0% with Oral Semaglutide versus Oral Comparators: An Exploratory Analysis of the PIONEER Studies.” Diabetes, Obesity & Metabolism 26 (2): 532–39. doi:10.1111/dom.15339.